Optimal heparin surface concentration and antithrombin binding capacity as evaluated with human non-anticoagulated blood in vitro

被引:74
作者
Andersson, J [1 ]
Sanchez, J
Ekdahl, KN
Elgue, G
Nilsson, B
Larsson, R
机构
[1] Univ Uppsala Hosp, Rudbeck Lab, Clin Immunol Sect, Dept Oncol Radiol & Clin Immunnol, SE-75185 Uppsala, Sweden
[2] Univ Kalmar, Dept Chem & Biomed Sci, SE-39182 Kalmar, Sweden
[3] Corline Syst AB, SE-75109 Uppsala, Sweden
来源
JOURNAL OF BIOMEDICAL MATERIALS RESEARCH PART A | 2003年 / 67A卷 / 02期
关键词
biocompatibility; blood; coagulation; complement activation; immobilized heparin;
D O I
10.1002/jbm.a.10104
中图分类号
R318 [生物医学工程];
学科分类号
0831 ;
摘要
Contact between blood and a biomaterial surface takes place in many applications and is known to activate the coagulation and complement systems. Heparin surface coatings have been shown to reduce blood activation upon contact with artificial surfaces. To establish the optimal heparin surface concentration, blood was incubated in a tubing loop model at 37degreesC. The tubing was coated with different surface concentrations of heparin and rotated at three different velocities. We demonstrate that the blood compatibility of a surface with regard to coagulation, complement, and platelet activation can be improved by increasing the heparin surface concentration in the 6-12 pmol antithrombin/ cm(2) concentration interval. The binding of factor H is not influenced by the increased heparin surface concentration, suggesting that this factor is not the primary regulator of complement on heparin surfaces. In addition, the heparin coating has no effect on the complement activation that occurs on gas surfaces in extracorporeal circuits. (C) 2003 Wiley Periodicals, Inc.
引用
收藏
页码:458 / 466
页数:9
相关论文
共 48 条
[1]  
Blackmore TK, 1996, J IMMUNOL, V157, P5422
[2]  
Blackmore TK, 1998, J IMMUNOL, V160, P3342
[3]  
Brynda E, 2000, J BIOMED MATER RES, V51, P249, DOI 10.1002/(SICI)1097-4636(200008)51:2<249::AID-JBM14>3.0.CO
[4]  
2-X
[5]   Characterization of ferritin adsorption onto gold [J].
Caruso, F ;
Furlong, DN ;
Kingshott, P .
JOURNAL OF COLLOID AND INTERFACE SCIENCE, 1997, 186 (01) :129-140
[6]   Heparin coating of the stent graft - effects on platelets, coagulation and complement activation [J].
Christensen, K ;
Larsson, R ;
Emanuelsson, H ;
Elgue, G ;
Larsson, A .
BIOMATERIALS, 2001, 22 (04) :349-355
[7]   BIOMATERIALS FOR BLOOD-CONTACTING APPLICATIONS [J].
COURTNEY, JM ;
LAMBA, NMK ;
SUNDARAM, S ;
FORBES, CD .
BIOMATERIALS, 1994, 15 (10) :737-744
[8]   ASSAY FOR HAGEMAN-FACTOR (FACTOR-XII) IN HUMAN-PLASMA BY MEANS OF CHROMOGENIC SUBSTRATE FOR PLASMA KALLIKREIN [J].
EGBERG, N ;
OVERMARKBERGGREN, I .
THROMBOSIS RESEARCH, 1983, 31 (06) :875-881
[9]   GENERATION OF IC3 AT THE INTERFACE BETWEEN BLOOD AND GAS [J].
EKDAHL, KN ;
NILSSON, B ;
PEKNA, M ;
NILSSON, UR .
SCANDINAVIAN JOURNAL OF IMMUNOLOGY, 1992, 35 (01) :85-91
[10]  
ELGUE G, 1993, ARTIF ORGANS, V17, P721